JPS6398359A - Feed additive composition for ruminant - Google Patents
Feed additive composition for ruminantInfo
- Publication number
- JPS6398359A JPS6398359A JP61243729A JP24372986A JPS6398359A JP S6398359 A JPS6398359 A JP S6398359A JP 61243729 A JP61243729 A JP 61243729A JP 24372986 A JP24372986 A JP 24372986A JP S6398359 A JPS6398359 A JP S6398359A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- lysine
- feed additive
- coating
- additive composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 241000282849 Ruminantia Species 0.000 title claims abstract description 23
- 239000003674 animal food additive Substances 0.000 title claims abstract description 8
- 239000011248 coating agent Substances 0.000 claims abstract description 54
- 238000000576 coating method Methods 0.000 claims abstract description 49
- 229920001577 copolymer Polymers 0.000 claims abstract description 39
- -1 etc. Substances 0.000 claims abstract description 33
- 150000001413 amino acids Chemical class 0.000 claims abstract description 28
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004472 Lysine Substances 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000002378 acidificating effect Effects 0.000 claims abstract description 8
- 229920000642 polymer Polymers 0.000 claims abstract description 7
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 claims abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004475 Arginine Substances 0.000 claims abstract description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 3
- 235000011054 acetic acid Nutrition 0.000 claims abstract description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000004310 lactic acid Substances 0.000 claims abstract description 3
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims abstract 4
- 150000007942 carboxylates Chemical class 0.000 claims abstract 2
- 235000019260 propionic acid Nutrition 0.000 claims abstract 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims abstract 2
- 229940024606 amino acid Drugs 0.000 claims description 37
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 10
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 7
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- 229930195712 glutamate Natural products 0.000 claims description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 3
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 241000283707 Capra Species 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 229940009098 aspartate Drugs 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- 235000019730 animal feed additive Nutrition 0.000 claims 5
- YQUDMNIUBTXLSX-UHFFFAOYSA-N 2-ethenyl-5-ethylpyridine Chemical compound CCC1=CC=C(C=C)N=C1 YQUDMNIUBTXLSX-UHFFFAOYSA-N 0.000 claims 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims 1
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 claims 1
- VJOWMORERYNYON-UHFFFAOYSA-N 5-ethenyl-2-methylpyridine Chemical compound CC1=CC=C(C=C)C=N1 VJOWMORERYNYON-UHFFFAOYSA-N 0.000 claims 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims 1
- 229940050411 fumarate Drugs 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims 1
- 229940070765 laurate Drugs 0.000 claims 1
- 229940070710 valerate Drugs 0.000 claims 1
- 239000002667 nucleating agent Substances 0.000 abstract description 16
- 210000003165 abomasum Anatomy 0.000 abstract description 10
- 150000001735 carboxylic acids Chemical class 0.000 abstract description 8
- 239000013543 active substance Substances 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000003513 alkali Substances 0.000 abstract description 2
- 210000004798 organs belonging to the digestive system Anatomy 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 35
- 235000001014 amino acid Nutrition 0.000 description 34
- 239000007853 buffer solution Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 17
- 230000005484 gravity Effects 0.000 description 14
- 210000004767 rumen Anatomy 0.000 description 14
- 239000011247 coating layer Substances 0.000 description 13
- 229960003646 lysine Drugs 0.000 description 12
- 239000008188 pellet Substances 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 239000008240 homogeneous mixture Substances 0.000 description 11
- 239000004570 mortar (masonry) Substances 0.000 description 11
- 230000000717 retained effect Effects 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 229920005989 resin Polymers 0.000 description 10
- 235000019766 L-Lysine Nutrition 0.000 description 9
- 150000001734 carboxylic acid salts Chemical class 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 229960005337 lysine hydrochloride Drugs 0.000 description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 description 5
- 239000008108 microcrystalline cellulose Substances 0.000 description 5
- CPYVQXAASIFAMD-KNIFDHDWSA-N (2s)-2-aminobutanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.NCCCC[C@H](N)C(O)=O CPYVQXAASIFAMD-KNIFDHDWSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 150000008545 L-lysines Chemical class 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000007884 disintegrant Substances 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 229940049920 malate Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 229960005357 lysine acetate Drugs 0.000 description 3
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 3
- 239000000347 magnesium hydroxide Substances 0.000 description 3
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 3
- 239000011824 nuclear material Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229940088623 biologically active substance Drugs 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229920006218 cellulose propionate Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 229940031958 magnesium carbonate hydroxide Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- IQFXJRXOTKFGPN-UHFFFAOYSA-N n-ethenyl-n-ethylethanamine Chemical compound CCN(CC)C=C IQFXJRXOTKFGPN-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- KGOLAIOCIQYQQY-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2,3-dihydroxybutanedioic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)C(O)C(O)C(O)=O KGOLAIOCIQYQQY-JEDNCBNOSA-N 0.000 description 1
- MPOCIPREOMFUSB-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPOCIPREOMFUSB-JEDNCBNOSA-N 0.000 description 1
- GBRIDGNTDLIRMN-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.NCCCC[C@H](N)C(O)=O GBRIDGNTDLIRMN-JEDNCBNOSA-N 0.000 description 1
- RGYMIAJZNKHQNJ-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;dodecanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCC(O)=O RGYMIAJZNKHQNJ-ZSCHJXSPSA-N 0.000 description 1
- MKAIBIAEULZAQC-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;hexadecanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCCCCCC(O)=O MKAIBIAEULZAQC-ZSCHJXSPSA-N 0.000 description 1
- HSQDJSAINPPZLR-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;octadecanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCCCCCCCC(O)=O HSQDJSAINPPZLR-ZSCHJXSPSA-N 0.000 description 1
- IYNFANLNWFSHQY-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.NCCCC[C@H](N)C(O)=O IYNFANLNWFSHQY-ZSCHJXSPSA-N 0.000 description 1
- MRPWIQCYSCNWFQ-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;propanoic acid Chemical compound CCC(O)=O.NCCCC[C@H](N)C(O)=O MRPWIQCYSCNWFQ-JEDNCBNOSA-N 0.000 description 1
- WUNWNURVJGOTHZ-YFKPBYRVSA-N (2s)-2-(hydroxymethylamino)-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@@H](C(O)=O)NCO WUNWNURVJGOTHZ-YFKPBYRVSA-N 0.000 description 1
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
- RYUVEEZMMFRGGS-NRFANRHFSA-N (2s)-4-methylsulfanyl-2-(octadecanoylamino)butanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCSC RYUVEEZMMFRGGS-NRFANRHFSA-N 0.000 description 1
- NOMBOSYULRDSOO-YRBAHSOBSA-N (2s)-4-methylsulfanyl-2-[[(z)-octadec-9-enyl]amino]butanoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCN[C@H](C(O)=O)CCSC NOMBOSYULRDSOO-YRBAHSOBSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LEWNYOKWUAYXPI-UHFFFAOYSA-N 1-ethenylpiperidine Chemical compound C=CN1CCCCC1 LEWNYOKWUAYXPI-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
- BWCZFWIRIAYLHO-UHFFFAOYSA-N 2-methyltetradecanoic acid Chemical compound CCCCCCCCCCCCC(C)C(O)=O BWCZFWIRIAYLHO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- SQKZZFHVQCSUHZ-UHFFFAOYSA-N 5-methyltetradecane Chemical compound CCCCCCCCCC(C)CCCC SQKZZFHVQCSUHZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 244000005894 Albizia lebbeck Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- RVEWUBJVAHOGKA-WOYAITHZSA-N Arginine glutamate Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RVEWUBJVAHOGKA-WOYAITHZSA-N 0.000 description 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000755266 Kathetostoma giganteum Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- RAQUISHGVNOAMH-JEDNCBNOSA-N Lysine Butyrate Chemical compound CCCC(O)=O.NCCCC[C@H](N)C(O)=O RAQUISHGVNOAMH-JEDNCBNOSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000212342 Sium Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- QJFIVDXVQKTKOO-UHFFFAOYSA-N acetic acid;diethylamino acetate Chemical compound CC(O)=O.CCN(CC)OC(C)=O QJFIVDXVQKTKOO-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 description 1
- QXJJQWWVWRCVQT-UHFFFAOYSA-K calcium;sodium;phosphate Chemical compound [Na+].[Ca+2].[O-]P([O-])([O-])=O QXJJQWWVWRCVQT-UHFFFAOYSA-K 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 239000006255 coating slurry Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- AWCMDQRPTDOBPC-ZSCHJXSPSA-N decanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CCCCCCCCCC(O)=O AWCMDQRPTDOBPC-ZSCHJXSPSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 125000004915 dibutylamino group Chemical group C(CCC)N(CCCC)* 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229960004419 dimethyl fumarate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FBDWCTWJJMORIU-UHFFFAOYSA-N magnesium;hexahydrate Chemical compound O.O.O.O.O.O.[Mg] FBDWCTWJJMORIU-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- NHGZEJHJHUHZDI-UHFFFAOYSA-N methyl 2-sulfanylbutanoate Chemical compound CCC(S)C(=O)OC NHGZEJHJHUHZDI-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は反芻動物用添加組成物に係漫、さらに詳しくは
アミノ酸を反炎動物に経口投与した場合、これがその第
−胃で分解されるのを防止しかつ第四胃以降の消化器管
内で、高い効率で消化もしくは吸収されるように保護し
た反芻動物用飼料添加組成物に関する。Detailed Description of the Invention (Industrial Application Field) The present invention relates to an additive composition for ruminants, and more specifically, when an amino acid is orally administered to a ruminant animal, the amino acid is degraded in the rumen of the animal. The present invention relates to a feed additive composition for ruminants that is protected from the abomasum and is digested or absorbed with high efficiency in the gastrointestinal tract from the abomasum onwards.
反狗動物では、一般に飼料の蛋白質アミノ酸はルーメン
で微生物酵醗により、かなりの部分がアンモニア、炭酸
ガスにまで分解され、本来の生物活性が失われる。ルー
メン内のバクテリアおよびプロトシアは、それ自身の成
長と増殖のためにアンモニアを利用し、増殖形成された
“微生物の蛋白質は単胃動物の胃に相当する第四胃に送
られこの両室で部分的に消化される。この工程は、小腸
で完了しそこで吸収される。In ruminant animals, a large portion of protein amino acids in feed is generally broken down into ammonia and carbon dioxide gas by microbial fermentation in the rumen, and the original biological activity is lost. Bacteria and Protocia within the rumen utilize ammonia for their own growth and multiplication, and the microbial proteins that are formed are transported to the abomasum, which corresponds to the stomach of monogastric animals, and are partially stored in both chambers. This process is completed in the small intestine, where it is absorbed.
(従来の技術とその問題点)
そこで、小腸での吸収効率を上げるため、第−胃での分
解を抑制することに関し、リジンを初めとする塩基性ア
ミノ酸の核を各種被覆剤で被覆する方法が提案されてい
るが、いずれの場合も、塩基性アミノ酸の鉱酸塩(代表
的には塩酸塩)が核剤として用いられている(特開昭s
ty、−ubgコ弘号公報、特開昭6/−ggg’73
号公報)。(Conventional techniques and their problems) Therefore, in order to increase absorption efficiency in the small intestine and suppress decomposition in the rumen, there is a method of coating the core of basic amino acids such as lysine with various coating agents. have been proposed, but in either case, a mineral salt of a basic amino acid (typically hydrochloride) is used as a nucleating agent (Japanese Patent Application Laid-open No.
ty, -ubg Koko Publication, JP-A-6/-ggg'73
Publication No.).
しかしながら、塩基性アミノ酸の供給源として、塩基性
アミノ酸の塩酸塩のごとき鉱酸塩を選ぶ場合には、製造
工程において多くの問題点があった。例えば、L−IJ
レジン供給源としてL−リジン−塩酸塩を使用すること
は製造プロセスでこの物質が金属を腐蝕し易く、原材料
を混合する際に混合機を摩耗させ易く、さらに。However, when a mineral acid salt such as a hydrochloride of a basic amino acid is selected as a source of a basic amino acid, there are many problems in the manufacturing process. For example, L-IJ
The use of L-lysine-hydrochloride as a resin source is likely to cause this material to corrode metals during the manufacturing process and wear out mixers when mixing raw materials.
また、被覆剤としては、例えば前記公開公報にはプロピ
オン酸モルホリノ酪酸セルロースまたはポリ(ビニルピ
リジン)のような合成高分子が提案されている。Furthermore, as a coating agent, synthetic polymers such as cellulose propionate morpholinobutyrate or poly(vinylpyridine) are proposed in the above-mentioned publication, for example.
しかしながら、特に1.− IJレジン塩酸塩は極めて
水に対する溶解度が太き(:lS℃でio。However, especially 1. - IJ resin hydrochloride has extremely high solubility in water (: IO at lS°C).
2の水にりO?溶解しまたその飽和の酸性度はpH5,
、S’であシ、この物質を含有するベレットはプロピオ
ン酸モルホリノ酪酸セルロースまたはポリ(ビニルピリ
ジン)のような感受性の高い重合体で被覆されると第−
胃環境下で溶出するのを防ぐことができず、第一胃液に
対応する緩衝溶液中での保護率と第四胃に対応する緩衝
シウムや水酸化マグネシウムのような塩基性物質との併
用が必要とされている(特開昭5lI−ttt、gユφ
号公報)。2 water paste O? The acidity of the solution and its saturation is pH 5,
, S', and pellets containing this material can be coated with a sensitive polymer such as cellulose propionate morpholinobutyrate or poly(vinylpyridine).
It cannot be prevented from eluting in the gastric environment, and the protection rate in buffer solutions corresponding to rumen fluid and the combination with basic substances such as buffered sium or magnesium hydroxide, which correspond to abomasum, are It is necessary (Unexamined Japanese Patent Publication No. 51-11-ttt, gyuφ
Publication No.).
一般的に、反芻動物の胃を飼料が順調に移動し、消化吸
収が効率よく行われるためには、生物学的活性物質を保
膿被榎した粒子の比重が胃液の比重すなわちハl〜へ−
に近いことが望ましく、第−胃の内容物の表面に浮遊し
たり、両底に沈降したりすることは滞留時間が長くなり
金物と併用する場合には、反芻動物用飼料としての、製
品比重が大きくなり過ぎるという問題があった。すなわ
ち、この場合にはL−リジン塩酸塩の比重が!、3であ
り、また塩基性炭酸マグネシウムや水酸化マグネシウム
の比重がそれぞれハg〜コ、λ、λ、3t、であること
から、必然的にハ3を越えてしまい、胃の低部に滞留し
易く、必要以上に胃内部での滞留時間が長くなり過ぎる
ことが懸念される。In general, in order for feed to move smoothly through the stomach of ruminants and for efficient digestion and absorption, the specific gravity of particles containing biologically active substances must be lower than the specific gravity of gastric juice, that is, halogen. −
It is desirable that the contents of the rumen float on the surface or settle to the bottom of the rumen, as this will increase the residence time and, if used together with hardware, the specific gravity of the product as feed for ruminants. The problem was that it became too large. That is, in this case, the specific gravity of L-lysine hydrochloride! , 3, and the specific gravity of basic magnesium carbonate and magnesium hydroxide are λ, λ, and 3t, respectively, so they inevitably exceed 3 and remain in the lower part of the stomach. There is a concern that the residence time in the stomach may be longer than necessary.
(問題点を解決するための手段)
本発明者らはこれらの諸問題を解決するべく鋭意検討し
、核物質として、少なくとも一種類ノ塩基性アミノ酸の
塩と、カルボン酸のアルカリ金属塩もしくはアルカリ土
類金属塩の少なくとも一種とを用いることが極めて効果
的であることを見出した。すなわち、カルボン酸のアル
カリ金属塩もしくはアルカリ土類金属塩を併用すること
により、第−胃環境下での塩基性アミノ酸塩の溶出を防
ぐことが出来るだけでなく無機質の塩基性物質を使用す
る場合に比較して比重の調節が容易となった。(Means for Solving the Problems) The present inventors have made extensive studies to solve these problems, and have used a salt of at least one nonbasic amino acid and an alkali metal salt or an alkali carboxylic acid as a nuclear material. It has been found that it is extremely effective to use at least one earth metal salt. In other words, by using an alkali metal salt or an alkaline earth metal salt of carboxylic acid in combination, it is possible not only to prevent the elution of basic amino acid salts in the rumen environment, but also to prevent the elution of basic amino acid salts in the rumen environment. It is easier to adjust the specific gravity compared to .
更に、炭素数117以上の長鎖のカルボン酸の塩を用い
る場合には、成型に際し滑沢剤としての効果をも期待す
ることができる。Furthermore, when a salt of a long-chain carboxylic acid having 117 or more carbon atoms is used, it can also be expected to have an effect as a lubricant during molding.
塩基性アミノ酸と併用するカルボン酸塩類の使用量は、
塩基性アミノ酸塩に対し通常重量比で0.0.2〜2.
0倍の範囲で、好ましくはo、o r〜ハθ倍の範囲で
用いられる。The amount of carboxylic acid salts used in combination with basic amino acids is
The usual weight ratio to the basic amino acid salt is 0.0.2 to 2.
It is used in the range of 0 times, preferably in the range of o, or to cθ times.
使用量がこれより少なすぎる場合には第−胃での保護効
果が小さく、量が多過ぎる場合には生物学的活性物質の
含有率が低下するのみならず、第四胃での生物学的活性
物質の溶出に時間、がかかり過ぎ、好ましくない。If the amount used is too small, the protective effect in the abomasum will be small, and if the amount is too large, not only will the content of biologically active substances decrease, but also the biological effect in the abomasum will be reduced. It takes too much time to elute the active substance, which is undesirable.
本発明において用いられる塩基性アミノ酸としてはリジ
ン、アルギニン、ヒスチジン、オルニチン、ヒドロキシ
リジンなどのアミノ酸があげられる。これらの塩基性ア
ミノ酸は二種以上を併用してもよい。Basic amino acids used in the present invention include amino acids such as lysine, arginine, histidine, ornithine, and hydroxylysine. Two or more of these basic amino acids may be used in combination.
塩基性アミノ酸の塩を構成する酸としては、無機酸と有
機酸があり、無機酸としては塩酸塩、硫酸塩などが使用
できる。有機酸としては、各種のカルボン酸が利用でき
る。Acids constituting basic amino acid salts include inorganic acids and organic acids, and examples of the inorganic acids include hydrochlorides and sulfates. Various carboxylic acids can be used as the organic acid.
塩基性アミノ酸やアルカリ金属、およびアルカリ土類金
属のカルボン酸塩を形成するために使用されるカルボン
酸としては、多くの組み合わせが考えられるが、カルボ
ン酸塩類を構成するカルボン酸成分としては1通常炭素
数二〜2弘程度のカルボン酸が適当である。カルボン酸
は飽和、または不飽和のカルボン酸のいずれでも良い。There are many possible combinations of carboxylic acids used to form carboxylic acid salts of basic amino acids, alkali metals, and alkaline earth metals, but one carboxylic acid component that constitutes carboxylic acid salts is usually Carboxylic acids having about 2 to 2 carbon atoms are suitable. The carboxylic acid may be either saturated or unsaturated.
また、カルボン酸の炭素鎖は直鎖型に限定されず、分岐
型のものでも良く、更に水酸基などの置換基を有してい
ても良い。なお、カルボン酸は必ずしも一塩基酸に限定
されず、二塩基酸などの多価カルボン酸を用いることが
可能である。Further, the carbon chain of the carboxylic acid is not limited to a linear type, but may be a branched type, and may further have a substituent such as a hydroxyl group. Note that the carboxylic acid is not necessarily limited to monobasic acids, and polycarboxylic acids such as dibasic acids can be used.
カルボン酸としては、例えば、酢酸、グロピオン酸、酪
酸、イソ酪酸、吉草酸、イソ吉草酸、カプロン酸、エナ
ント酸、カプリル酸、ペラルゴン酸、カプリン酸、ラウ
リン酸、トリデカン酸、−一メチルテトラデカン酸、5
−メチルテトラデカン醗、コ、2−ジメチルテトラデカ
ン酸。Examples of carboxylic acids include acetic acid, glopionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, tridecanoic acid, -monomethyltetradecanoic acid. , 5
-Methyltetradecane, 2-dimethyltetradecanoic acid.
メチルテトラデカン酸、ミリスチシ酸、パルミチン酸、
ステアリン酸、などの脂肪族モノカルボン酸類、オレイ
ン酸、リノール酸、リルン酸7などの脂肪族不飽和モノ
カルボン酸、マロン酸、コハク酸、フマール酸、アジピ
ン酸、グルタル酸、アゼライン酸、セバシン酸、/、2
0−エイコサメチレンジカルボン酸などの脂肪族飽和お
よび不飽和ジカルボン酸、2−ヒドロキシ−グーメチル
メルカプト酪酸、乳酸、クエン酸、インクエン酸、グリ
コール酸、リンゴ酸、酒石酸などのオキシ酸があげられ
る。さらに、・桂皮酸、マンデル酸などの芳香族カルボ
ン酸があげられる。この他、アルギン酸、パントテン酸
などのカルボン酸もあげられる。酸性アミノ酸としては
アスパラギン酸とグルタミン酸があ B −
けられる。Methyltetradecanoic acid, myristic acid, palmitic acid,
Aliphatic monocarboxylic acids such as stearic acid, aliphatic unsaturated monocarboxylic acids such as oleic acid, linoleic acid, and lylunic acid 7, malonic acid, succinic acid, fumaric acid, adipic acid, glutaric acid, azelaic acid, and sebacic acid. ,/,2
Aliphatic saturated and unsaturated dicarboxylic acids such as 0-eicosamethyl dicarboxylic acid, 2-hydroxy-gumethylmercaptobutyric acid, oxyacids such as lactic acid, citric acid, incitric acid, glycolic acid, malic acid, tartaric acid and the like. Further examples include aromatic carboxylic acids such as cinnamic acid and mandelic acid. Other examples include carboxylic acids such as alginic acid and pantothenic acid. Aspartic acid and glutamic acid are used as acidic amino acids.
なお、上述のカルボン酸塩類は必ずしも単品である必要
は無く−カルボン酸塩類を構成するカルボン酸成分や対
カチオン成分の異なる二種以上のカルボン酸塩類の混合
物も使用できる。Note that the above-mentioned carboxylic acid salts do not necessarily have to be used alone; a mixture of two or more carboxylic acid salts having different carboxylic acid components and counter-cation components constituting the carboxylic acid salts can also be used.
またカルボン酸塩類は結晶水を持っているものでも利用
できる。Carboxylic acid salts can also be used even if they have water of crystallization.
これらの塩基性アミノ酸と無機酸、カルボン酸および/
または酸性アミノ酸との塩は核剤として、アミノ酸の供
給源として利用できる。These basic amino acids and inorganic acids, carboxylic acids and/or
Alternatively, salts with acidic amino acids can be used as a nucleating agent and as a source of amino acids.
具体例としてはL−IJレジン塩酸塩、硫酸・コム−リ
ジン塩、L−リジン−L−アスパラギン酸塩、L−リジ
ン−L−グルタミン酸塩、L−リジン酢酸塩、L−リジ
ンプロピオン酸塩、L−リジン乳酸塩、L−リジン酒石
酸塩、L−リジン酪酸塩、フマール酸・コム−リジン塩
。Specific examples include L-IJ resin hydrochloride, sulfuric acid/com-lysine salt, L-lysine-L-aspartate, L-lysine-L-glutamate, L-lysine acetate, L-lysine propionate, L-lysine lactate, L-lysine tartrate, L-lysine butyrate, fumaric acid comb-lysine salt.
コハク酸・2L−リジン塩、L−リジン吉草酸塩、r、
−IJレシンユーヒドロキシ−グーメチルメルカプト酪
酸塩、L−リジンクエン酸塩、L−リジンカプロン酸塩
、L−リジンカプリル酸塩、L−リジン桂皮酸塩、L−
リジンカプリン酸塩、L−リジンラウリル酸塩、L−リ
ジンパルミチン酸塩、L−リジンステアリン酸塩、L−
アルギニン塩酸塩、L−アルギニン−L−グルタミン酸
塩、L−ヒスチジン塩酸塩などがあげられる。Succinic acid 2L-lysine salt, L-lysine valerate, r,
-IJ resin uhydroxy-gu methyl mercaptobutyrate, L-lysine citrate, L-lysine caproate, L-lysine caprylate, L-lysine cinnamate, L-
Lysine caprate, L-lysine laurate, L-lysine palmitate, L-lysine stearate, L-
Examples include arginine hydrochloride, L-arginine-L-glutamate, and L-histidine hydrochloride.
塩基性アミノ酸のカルボン酸塩類を調整する方法として
は、水や有機溶媒の存在下、室温ないし加熱条件下に中
和反応を行う方法が簡便である。また、無溶媒下で反応
させることも可能である。これらの反応によシ得られた
塩は、単独で利用してもよいが、他の抗生物質、栄養剤
。A convenient method for preparing carboxylic acid salts of basic amino acids is to carry out a neutralization reaction in the presence of water or an organic solvent at room temperature or under heating conditions. It is also possible to carry out the reaction without a solvent. The salts obtained by these reactions may be used alone, but may also be used as other antibiotics or nutritional agents.
獣医薬などの生物学的活性物質と併用して用いることも
もちろん可能である。本発明において塩基性アミノ酸と
併用できる生物学的活性物質は、動物、特に反芻動物に
投与することによシ、体重増加、泌乳量増加、疾病の予
防または治療液内に存在する微生物により分解され失活
しやすい物質を対象とする。生物学的活性物質として、
メチオニン、スレオニン、トリプトファンなどのアミノ
酸類、N−アシルアミノ酸たとえば、N−ステアロイル
メチオニン、N−オレイルメチオニン等N−ヒドロキシ
メチルメチオニンのカルシウム塩、リジン塩酸塩などの
アミノ酸誘導体類、コーヒドロキシーグーメチルメルカ
プト酪酸およびそのカルシウム塩などのアミノ酸のヒド
ロキシ同族化合物類、羽毛粉末、魚粉床、カゼイン、ば
れいしょ蛋白などの蛋白質類、ビタミンA1 ビタミン
A−酢酸塩、ビタミン人−パルミチン酸塩、ビタミンD
3、ビタミンE、ニコチン酸、ニコチン酸アミド、パン
トテン酸カルシウム、β−カロチンなどの/ビタミン類
、酸性プロテアーゼなどの酵素類、ブドウ糖などの炭水
化物類、抗生物質たとえばペニシリン、テトラサイクリ
ン等、駆虫薬例えばレバミゾール、ネグフオン等などの
獣医薬類等を挙げることができる。これらは単独でまた
は組み合わせて用いられる。Of course, it is also possible to use it in combination with biologically active substances such as veterinary drugs. The biologically active substance that can be used in combination with basic amino acids in the present invention can be administered to animals, especially ruminants, to increase body weight, increase milk production, prevent disease, or be degraded by microorganisms present in the therapeutic solution. Targets substances that are easily deactivated. As a biologically active substance,
Amino acids such as methionine, threonine, and tryptophan; N-acyl amino acids such as N-stearoylmethionine and N-oleylmethionine; calcium salts of N-hydroxymethylmethionine; amino acid derivatives such as lysine hydrochloride; Hydroxy homologues of amino acids such as butyric acid and its calcium salts, proteins such as feather powder, fishmeal bed, casein, potato protein, vitamin A1, vitamin A-acetate, vitamin palmitate, vitamin D
3. Vitamins such as vitamin E, nicotinic acid, nicotinic acid amide, calcium pantothenate, and β-carotene, enzymes such as acid protease, carbohydrates such as glucose, antibiotics such as penicillin and tetracycline, and anthelmintics such as levamisole. , Negufuon, and other veterinary medicines. These may be used alone or in combination.
これらの核剤は通常、造粒用の粘結剤、賦形剤、崩壊剤
、比重調節用の各種添加剤lなど飼料用添加剤として生
物学的に反芻動物に受は入れられる物質であれば、これ
らと併用して使用することが、好都合である。These nucleating agents are usually substances that are biologically acceptable to ruminants as feed additives, such as binders for granulation, excipients, disintegrants, and various additives for adjusting specific gravity. For example, it is convenient to use them in combination.
例えば、粘結剤としては、ポリビニルピロリドン、ヒド
ロキシプロピルセルロース、ポリビニルアルコール、ア
ラビアゴム、グアガム、アルギン酸ナトリウム、繊維素
グリコール酸ナトリウム、ポリアクリル酸ナトリウムな
ど、賦形剤としてはラクトース、マンニット、結晶セル
ロースなど、崩壊剤としてはバレイショデンブン、コー
ンスターチ、カルボキシメチルセルロースカルシウム、
カルボキシメチルセルロースナ) IJウム、結晶セル
ロース、比重調節用の各種添加剤などを含有していても
良い。For example, binders include polyvinylpyrrolidone, hydroxypropylcellulose, polyvinyl alcohol, gum arabic, guar gum, sodium alginate, sodium cellulose glycolate, sodium polyacrylate, and excipients include lactose, mannitol, and crystalline cellulose. Disintegrants include potato starch, cornstarch, carboxymethyl cellulose calcium,
It may contain carboxymethyl cellulose, crystalline cellulose, various additives for adjusting specific gravity, etc.
この他、地六書館発行の薬剤製造法(上)医薬品開発基
礎講座X1(pp133〜/、1ダ)K記載されている
結合剤、賦形剤、崩壊剤、滑沢剤。In addition, there are binders, excipients, disintegrants, and lubricants described in Pharmaceutical Manufacturing Methods (Part 1) Pharmaceutical Development Basic Course X1 (pp133-/1 da) K published by Jirokushokan.
着色剤、矯味剤、矯臭剤、など公知の添加剤を必要に応
じ使用することができる。Known additives such as coloring agents, flavoring agents, and flavoring agents can be used as necessary.
塩基性アミノ酸と無機酸、カルボン酸または/および酸
性アミノ酸との塩を含有する核に対する被覆剤の使用割
合は反芻動物の第−胃での長時間にわたる滞留時間の間
該物質を安定な状態に保護しかつ、第四胃での比較的短
時間の滞留時間内に核物質を速やかに溶出させることが
必要で、被覆剤に供する粒子の大きさによシ、また、使
用する被覆剤の種類によp必要とする量は変化するが、
通常、被覆前の粒子の10〜ユ00 vrt%好ましく
は15〜gOwt%の範囲で使用される。The rate of use of coating agents on the core containing salts of basic amino acids and inorganic acids, carboxylic acids or/and acidic amino acids is such that the substance remains stable during extended residence times in the rumen of ruminants. It is necessary to protect and elute the nuclear material quickly within a relatively short residence time in the abomasum, and the size of the particles to be coated and the type of coating used are important. The amount required varies depending on the
Usually, it is used in a range of 10 to 100 vrt%, preferably 15 to 15 gowt% of the particles before coating.
本発明に使用する被覆粒子は反芻動物への経口投与に適
応するものであることが必要である。The coated particles used in the present invention must be suitable for oral administration to ruminants.
そのため、被覆粒子の直径は002〜10Mm好ましく
はo、s”−5naの大きさに成型して用いられる。粒
径が小さいと第−胃での保護が充分でなく、これよシ大
きくなると反芻の際に噛み砕かれる粒子の割シ合いが増
大し、好ましくない。Therefore, the diameter of the coated particles is 0.02 - 10 mm, preferably 0.5 mm. The proportion of particles that are crushed during this process increases, which is undesirable.
また、被覆粒子は第一胃内での滞留時間が短くなるよう
、1.θ〜ハリの間に調節することが好捷しい。核物質
の種類により比重が異なるが。In addition, the coated particles are designed to shorten their residence time in the rumen.1. It is preferable to adjust it between θ and firmness. The specific gravity varies depending on the type of nuclear material.
その比重を調節するために、軽くするためKは、シラス
バルーンや微小中空ガラス球などを、また、重くするた
めには不活性無機物質として反芻動物に受は入れられる
金属酸化物や炭酸塩が用いられる。In order to adjust the specific gravity, to make it lighter, K can be made of glass balloons or microscopic hollow glass spheres, and to make it heavier, metal oxides and carbonates, which are accepted by ruminants as inert inorganic substances, can be used. used.
本発明の組成物の製造については、塩基性アミノ酸の塩
とカルボン酸塩および賦形剤、崩壊剤などの添加剤を必
要に応じ加え、まず乾式混合する。これに結合剤を溶解
した水或いはエチルアルコールを加えて遠心流動コーデ
ィング装を用いて、適当な粒径の粒子とする。ついで。To produce the composition of the present invention, a salt of a basic amino acid, a carboxylic acid salt, and additives such as an excipient and a disintegrant are added as necessary, and the mixture is first dry mixed. Water or ethyl alcohol in which a binder is dissolved is added to this, and particles of an appropriate size are formed using a centrifugal flow coating device. Next.
通常はtto−go℃の温度範囲で30〜二時間乾燥す
る。Drying is usually carried out at a temperature range of 30 to 2 hours.
反與動物の第−胃の胃液に対応する弱酸性ないし弱アル
カリ性の条件下では安定であるが第四胃の胃液に対応す
る強酸性の条件下で崩壊、膨潤(ここで膨潤とは被覆さ
れた粒子が第四胃に存在する時間内に塩基性アミノ酸の
塩の大部分が被覆している合成高分子の膜を通過して溶
出できる程度に膨らむことを意味する。)、もしくは溶
出する性質を有する物質の例としては、ベンジルアミノ
メチルセルロース、ジメチルアミノメチルセルロース、
ピペリジルエチルヒドロキシエチルセルロース、セルロ
ースアセテートジエチルアミノアセテート、セルロース
アセテートジブチルアミノヒドロキシグロビルエーテル
、エチルセルロース−N、N −シェチルアミノヒドロ
キシグロビルエーテル、エチルセルロースビリジノヒド
ロキシグロビルエーテル、ジエチルアミノメチルセルロ
ース、ピペリジルエチルヒドロキシエチルセルロース、
等のセルロース誘導体。It is stable under weakly acidic to weakly alkaline conditions corresponding to the gastric juice in the rumen of ruminants, but disintegrates and swells under strongly acidic conditions corresponding to the gastric juice in the abomasum (swelling here refers to This means that during the time that the particles remain in the abomasum, they swell to such an extent that they can pass through the synthetic polymer membrane that covers most of the basic amino acid salts and elute. Examples of substances having this include benzylaminomethylcellulose, dimethylaminomethylcellulose,
piperidylethyl hydroxyethyl cellulose, cellulose acetate diethylamino acetate, cellulose acetate dibutylamino hydroxyglobyl ether, ethylcellulose-N,N-shetylaminohydroxyglobyl ether, ethylcellulose viridino hydroxyglobyl ether, diethylaminomethylcellulose, piperidylethylhydroxyethylcellulose,
Cellulose derivatives such as.
N、N−ジエチルビニルアミンルビニルアセテート共重
合体、ビニルピペリジンルビニルアセテ−)共重合体、
ビニルジエチルアミンルビニルアセテート共重合体、ビ
ニルベンジルアミン〜ビニルアセテート共重合体、ポリ
ビニルジエチルアミノアセトアセタール、ポリビニルベ
ンリビニルアセタールジエチルアミンアセテート。N,N-diethylvinylamine rubinyl acetate copolymer, vinylpiperidine rubinyl acetate copolymer,
Vinyldiethylamine rubinyl acetate copolymer, vinylbenzylamine-vinyl acetate copolymer, polyvinyldiethylaminoacetoacetal, polyvinylbenrivinyl acetal diethylamine acetate.
等のアセテート訪導体。Acetate conductor such as.
ポリジエチルアミノメチルスチレン、ポリジェタノール
アミノメチルスチレン、ポリジメチルアミノエチル(メ
タ)アクリレート、ジメチルアミノエチルアクリレ−ト
ルメチル(メタ)アクリレート共重合体、ジメチルアミ
ノエチルメタクリレ−トルメチル(メタ)アクリレート
共重合体、ポリツーメチル−S−ビニルピリジン、ポリ
コーエチルー5−ビニルピリジン、などのポリアルキル
ビニルピリジン、ポリグービニルピリジン、ポリグービ
ニルピリジン、ナトのポリビニルピリジン。Polydiethylaminomethylstyrene, polyjetanolaminomethylstyrene, polydimethylaminoethyl (meth)acrylate, dimethylaminoethyl acrylate tolmethyl (meth)acrylate copolymer, dimethylaminoethyl methacrylate tolmethyl (meth)acrylate copolymer , polyalkylvinylpyridine such as poly2methyl-S-vinylpyridine, polycoethyl-5-vinylpyridine, polygovinylpyridine, polygovinylpyridine, and polyvinylpyridine.
ニービニルピリジン〜スチレン共重合体、弘−ビニルピ
リジン−スチレン共重合体、などのビニルピリジン−ス
チレン共重合体、
ツーエチル−5−ビニルピリジン〜スチレン共重合体、
:1−メチル−5−ビニルピリジン−スチレン共重合体
、などのビニルアルキルピリジン−スチレン共重合体、
ツービニルピリジン〜アクリロニトリル共重合体、など
のビニルピリジン−アクリロニトリル共重合体。Vinylpyridine-styrene copolymers such as vinylpyridine-styrene copolymer, Hiro-vinylpyridine-styrene copolymer, two-ethyl-5-vinylpyridine-styrene copolymer,
: Vinyl alkylpyridine-styrene copolymers such as 1-methyl-5-vinylpyridine-styrene copolymers; vinylpyridine-acrylonitrile copolymers such as two-vinylpyridine-acrylonitrile copolymers.
ビニルエチルピリジン−アクリロニトリル共重合体、メ
チルビニルピリジン−アクリロニトリル共重合体、ニー
ビニルピリジン−メチルメタクリレート共重合体、弘−
ビニルピリジン−メチルメタクリレート共重合体、など
のビニルピリジン−メチルメタクリレート共重合体、−
一ビニルピリジン〜ブタジェン共重合体、ニービニルピ
リジン〜ブタジェン〜スチレン共重合体、ビニルピリジ
ン−スチレン共重合体、2−ビニルピリジン〜スチレン
〜メチルメタクリレート共重合体、などのビニルピリジ
ンまたはアルキルビニルピリジンの重合体または他のビ
ニール化合物との共重合体、
N、N−ジメチルアミノプロピル(メタ)アクリルアミ
ドルアクリロニトリル共重合体、N、N−ジメチルアミ
ンプロピル(メタ)アクリルアミドルスチレン共重合体
、N、N−ジアルキルアミノアルキルメタクリルアミド
ルアクリロニトリル共重合体、ビニルピリジン−アクリ
ロニトリル共重合体、メチルビニルピリジン−アクリロ
ニトリル共重合体、メチルビニルピリジン〜スチレン共
重合体等のポリビニル誘導体。Vinylethylpyridine-acrylonitrile copolymer, methylvinylpyridine-acrylonitrile copolymer, vinylpyridine-methylmethacrylate copolymer, Hiro-
vinyl pyridine-methyl methacrylate copolymers, such as vinyl pyridine-methyl methacrylate copolymers, -
of vinylpyridine or alkylvinylpyridine such as monovinylpyridine-butadiene copolymer, vinylpyridine-butadiene-styrene copolymer, vinylpyridine-styrene copolymer, 2-vinylpyridine-styrene-methyl methacrylate copolymer, etc. Polymers or copolymers with other vinyl compounds, N,N-dimethylaminopropyl(meth)acrylamide middle acrylonitrile copolymer, N,N-dimethylaminepropyl(meth)acrylamide middle styrene copolymer, N,N - Polyvinyl derivatives such as dialkylaminoalkyl methacrylamide middle acrylonitrile copolymer, vinylpyridine-acrylonitrile copolymer, methylvinylpyridine-acrylonitrile copolymer, and methylvinylpyridine-styrene copolymer.
スチレン〜ジメチルフマレートまたはスチレン−マレイ
ミド共重合体のN、N−ジエチルエチレンジアミン誘導
体、
テレフタル酸またはマレイン酸とN −n−ブチルジェ
タノールアミンの反応網金物、グロビレングリコール〜
マレイン酸ポリエステルのベンジルアミン付加物等を挙
げることができる。Styrene - N,N-diethylethylenediamine derivative of dimethyl fumarate or styrene-maleimide copolymer, reaction mesh of terephthalic acid or maleic acid and N-n-butyljetanolamine, globylene glycol -
Examples include benzylamine adducts of maleic acid polyesters.
被覆用は pHjt以下の酸性領域で水に溶解する合成
高分子であるが、この他にタルク、アルミニウム、マイ
カ、シリカ、ステアリン酸、ステアリン酸アルミニウム
、ステアリン酸マグネシウム、などの融着防止剤を含有
していても差し支えない。The coating material is a synthetic polymer that dissolves in water in an acidic region below pHjt, but it also contains anti-fusing agents such as talc, aluminum, mica, silica, stearic acid, aluminum stearate, and magnesium stearate. There is no harm in doing so.
被覆用の合成間分子は通常溶媒に溶解させた状態で使用
するが、乳化剤を用い、エマルジョンとして使用しても
良い。The synthesis molecules for coating are usually used in a state dissolved in a solvent, but they may also be used in the form of an emulsion using an emulsifier.
コーティングに適した溶媒としては、塩化メチレン、ク
ロロホルム、イソプロパツール、エチルアルコール、メ
チルアルコール、酢酸エチル、アセトン、メチルエチル
ケトン、トルエンまたはこれらの混合物があげられる。Suitable solvents for coating include methylene chloride, chloroform, isopropanol, ethyl alcohol, methyl alcohol, ethyl acetate, acetone, methyl ethyl ketone, toluene or mixtures thereof.
被覆する際に、被覆用の原材料は融着防止剤などが懸濁
した状態で供給しても良いし捷た、別々に供給しても良
い。At the time of coating, the raw materials for coating may be supplied in a state in which anti-fusing agents and the like are suspended, or they may be supplied separately in a shredded form.
顆粒のコーティング方法としては種々の方法が知られて
おり、例えば、遠心造粒コーティング法、流動コーティ
ング法、パンコーディング法など一般的なコーティング
方法のどれをとってもよい。この他に化学的修飾法や、
マイクロカプセル化法も考えられる。Various methods are known for coating granules, and for example, any of the general coating methods such as centrifugal granulation coating, fluid coating, and pan-coating may be used. In addition, chemical modification methods,
Microencapsulation methods are also conceivable.
反芻動物は特に限定されないが、通常は、牛、羊、また
は山羊である。Ruminants are typically, but not limited to, cows, sheep, or goats.
(実施例)
以下に5本発明の方法について代表的な実施例を示し、
更に具体的に説明する。なお、これらは、単なる例示で
あシ、本発明はこれらの例によって何等制約を受けるも
のでは無い。(Example) Below are five representative examples of the method of the present invention,
This will be explained more specifically. Note that these are merely examples, and the present invention is not limited in any way by these examples.
反芻動物に対する飼料添加剤として有用かつ実用的であ
るためには1本発明における被覆された粒子中のアミノ
酸もしくはアミノ酸塩類の振盪して放出されなければな
らないと考えられる。したがって、以下の実施例では前
記の基準にしたがって評価を行なった。In order to be useful and practical as a feed additive for ruminants, it is believed that the amino acids or amino acid salts in the coated particles of the present invention must be released upon shaking. Therefore, the following examples were evaluated according to the above-mentioned criteria.
〔実施例1〕
〔造粒〕
L−リジン−塩酸塩り3y−、ステアリン酸カルシウム
?、/7.ポリビニルピロリドン(K−−20=
q o ) s、o fを乳鉢で混合することによりほ
ぼ均質な混合物を得た。此の粉末状混合物に水139−
を少しずつ加えながら良く練り合わせてパテ状にした。[Example 1] [Granulation] L-lysine-hydrochloride 3y-, calcium stearate? , /7. A substantially homogeneous mixture was obtained by mixing polyvinylpyrrolidone (K--20=qo)s,of in a mortar. Add 139% of water to this powder mixture.
was added little by little and kneaded well to form a putty.
これをコ、2醜φの孔径を有する押出し機よシ押出し、
切断することにより、直径約ユ、Owgの円柱状ペレッ
トを得た。このペレットをマルメライザー丸め、常温で
3時間乾燥させ、引き続いて熱風循環式恒温槽中でt、
OCで5時間乾燥させた。乾燥ペレットを篩分し。Extrude this using an extruder with a hole diameter of 2 mm,
By cutting, cylindrical pellets with a diameter of about 1,000 kg were obtained. The pellets were rolled into marmerizer balls, dried at room temperature for 3 hours, and then placed in a hot air circulation constant temperature bath for t.
Dry in OC for 5 hours. Sift the dried pellets.
g−9メツシユ(:1.o o −s、3t rtmφ
)の範囲のペレットを得た。g-9 mesh (:1. o o -s, 3t rtmφ
) were obtained.
〔コーテイング液の調合および粒子の被覆〕グービニル
ピリジンとスチレンとの70二30重量比の共重合体(
エタノール中0.!ff/diでの還元粘度:ηsp/
c = 0.り5)aoy−、アルミニウム粉末32.
3 f−、タルク粉末3 u、5 S’sステアリン酸
ty、の混合物にエチルアルコールboy−を加えて室
温で3時間攪拌しコーテイング液を調整した。実施例1
と同様の方法でコーティングし、コーティング層の重量
が被覆された粒子全体のJ O,/ wt%になるまで
被覆を行った。[Preparation of coating liquid and coating of particles] Copolymer of govinylpyridine and styrene in a weight ratio of 70 to 30 (
0 in ethanol. ! Reduced viscosity at ff/di: ηsp/
c = 0. 5) aoy-, aluminum powder 32.
Ethyl alcohol boy was added to a mixture of 3 F-, 3 U of talc powder, and 5 S's stearic acid ty, and the mixture was stirred at room temperature for 3 hours to prepare a coating liquid. Example 1
Coating was performed in the same manner as above until the weight of the coating layer became JO,/wt% of the entire coated particles.
L IJレジン塩酸塩を核剤とする粒子の被覆物を反
徒動物の第一胃液に相当するMadougall緩衝溶
液中39Cで2’1時間振盪後保持されていたL −I
Jレジン塩酸塩はq s、o %であった。The coating of particles with L IJ resin hydrochloride as a nucleating agent was retained after shaking for 2'1 hour at 39 C in a Madougall buffer solution corresponding to the rumen juice of a ruminant.
J resin hydrochloride was q s, o %.
また第四胃液に対応するC1ark Lubs 緩衝
溶液中39℃で二時間振盪するとL−IJレジン塩酸塩
はtoo、o%溶出した。このことは、このペレットが
反芻動物用飼料として有用であることを示している。Further, when the mixture was shaken at 39° C. for 2 hours in a C1ark Lubs buffer solution corresponding to abomasal juice, too much of the L-IJ resin hydrochloride was eluted. This indicates that this pellet is useful as feed for ruminants.
L−リジン−塩酸塩り3?、ステアリン酸ナトリウム?
、/?、ポリビニルピロリドン(K−qo)s、oy、
マイクロクリスタリンセルロー′スlユ、9ンを乳鉢で
混合することによシはぼ均質な混合物を得た。此の粉末
状混合物に水/<Z?を少しずつ加えながら良く練り合
わせてパテ状にした。これを実施例/と同様な方法で造
粒し、95チ収率でg−9メツシユ(ユ、00−ユ、3
gmφ)の範囲のペレットを得た。L-lysine-hydrochloride 3? , sodium stearate?
,/? , polyvinylpyrrolidone (K-qo)s, oy,
A nearly homogeneous mixture was obtained by mixing 9 ml of microcrystalline cellulose in a mortar. Add water to this powder mixture/<Z? was added little by little and kneaded well to form a putty. This was granulated in the same manner as in Example/, and g-9 mesh (YU, 00-U, 3
gmφ) were obtained.
リレートとの共重合体、Rohm Pharma社(西
独)〕30y−、アルミニウム粉末、?5?、タルク粉
末3S?の混合物にエチルアルコールt、oy−q加え
て室温で3時間攪拌しコーテイング液を調整した。Copolymer with rylate, Rohm Pharma (West Germany)] 30y-, aluminum powder, ? 5? , talc powder 3S? Ethyl alcohol t and oy-q were added to the mixture and stirred at room temperature for 3 hours to prepare a coating liquid.
このコーテイング液を用い、コーティング層の重量が被
覆された粒子全体の30.’l wt%になるまで被覆
を行った。Using this coating liquid, the weight of the coating layer was 30% of the total coated particles. Coating was carried out until 1 wt%.
このようにして得られたL−リジン−塩酸塩を核剤とす
る粒子の被覆物をMcdougall緩衝溶液中JqC
で=q時間振盪後保持されていたL−リジン−塩酸塩は
9へlI%であった。またC1ark Lubs 緩
衝溶液中39℃で1時間振盪するとL−リジン−塩酸塩
は/ 00.0%溶出した。The thus obtained particle coating using L-lysine hydrochloride as a nucleating agent was subjected to JqC in McDougall buffer solution.
The L-lysine-hydrochloride retained after shaking for = q hours was 9 to 1I%. Further, when the mixture was shaken in C1ark Lubs buffer solution at 39°C for 1 hour, L-lysine-hydrochloride was eluted at 0.00%.
このことは、ペレットが反芻動物用飼料として有用であ
ることを示している。This indicates that the pellets are useful as feed for ruminants.
〔実施例3〕
L−リジンの酢酸塩50?、ラウリン酸カルシウム10
f、シリカ粉末20y−、ポリビニルピロリドン(K−
qo)2.slを乳鉢で混合することによシはぼ均質な
混合物を得た。此の粉末状混合物に水9.51を少しず
つ加えながら良く練り合わせてパテ状にした。これを実
施例1と同様に造粒し1g−9メツシユ(2,OO−ユ
、、3gM11φ)の範囲のペレットを得た。[Example 3] L-lysine acetate 50? , calcium laurate 10
f, silica powder 20y-, polyvinylpyrrolidone (K-
qo)2. A nearly homogeneous mixture was obtained by mixing the sl in a mortar. To this powdery mixture, 9.51 g of water was added little by little and kneaded well to form a putty. This was granulated in the same manner as in Example 1 to obtain pellets in the range of 1 g-9 mesh (2, OO-U, 3 gM 11φ).
実施例/と同一の溶液でコーティングし、コーティング
層の重量が被覆された粒子全体のJ O,1wt%にな
るまで被覆を行った。Coating was carried out using the same solution as in Example/1 until the weight of the coating layer was 1 wt % J O of the entire coated particles.
1、− IJリジン酢酸塩核剤とする粒子の被覆物をM
cdougall緩衝溶液中jqcでラダ時間振盪後保
持されていたL−リジン酢酸塩は9り、コチであった。1, - The coating of particles with IJ lysine acetate nucleating agent as M
The amount of L-lysine acetate retained after shaking for an hour with jqc in cdougall buffer was 90%.
また、C1ark Lubs 緩衝溶液中39℃で3
時間振盪するとL−リジン酢酸塩は9g、3多溶出した
。In addition, 3% at 39°C in C1ark Lubs buffer solution.
After shaking for hours, 9 g of L-lysine acetate was eluted.
実施例3においてコーティング用スラリー液中のポリマ
ーをグービニルピリジンとスチレンとの共重合体からニ
ービニルピリジンとスチレンとの共重合体に変更した以
外は同様な実験を行った。A similar experiment was conducted in Example 3 except that the polymer in the coating slurry was changed from a copolymer of gouvinylpyridine and styrene to a copolymer of vinylpyridine and styrene.
ツービニルピリジンとスチレンとのり0:30重量比の
共重合体(エタノール中0.5flldiでの還元粘度
:ηaV′c −0,’lり) 3of、アルミニウ
ム粉末32.!;9f−タルク粉末3ユJ y−、ステ
アリン酸51の混合物にエチルアルコール6θ?を加え
て室温で3時間攪拌しコーテイング液を調整した。実施
例/と同様の方法でコーティングし、コーディング層の
重量が被覆された粒子全体のユ9.9wt%になるまで
被覆を行った。Copolymer of vinylpyridine and styrene in a weight ratio of 0:30 (reduced viscosity at 0.5fldi in ethanol: ηaV'c -0,'l) 3of, aluminum powder 32. ! ethyl alcohol 6θ in a mixture of 9f-talc powder 3Jy-, stearic acid 51? was added and stirred at room temperature for 3 hours to prepare a coating solution. Coating was carried out in the same manner as in Example/1 until the weight of the coating layer became 9.9 wt % of the entire coated particles.
L IJリジン酢酸塩核剤とする粒子の被覆物をMc
dougall緩衝溶液中39℃でラダ時間振盪後保持
されていたI、 −IJリジン酢酸塩990g%であっ
た。また、C1ark Luba 緩衝溶液中39℃
で3時間振盪するとL IJリジン酢酸塩gaOチ溶
出した。Mc
There was 990 g% of I, -IJ lysine acetate that was retained after shaking for a ladder hour at 39° C. in Dougall's buffer solution. Also, at 39°C in C1ark Luba buffer solution.
After shaking for 3 hours, LIJ lysine acetate gaO was eluted.
L−リジンの酢酸塩100g−、タルク20.0?、マ
イクロクリスタリンセルロースJ Of。L-lysine acetate 100g, talc 20.0? , Microcrystalline Cellulose J Of.
繊維索グリコール酸ナトリウム109−を乳鉢で混合す
ることによりほぼ均質な混合物を得た。A nearly homogeneous mixture was obtained by mixing the sodium fibrous glycolate 109 in a mortar.
此の粉末状混合物に水:1!;9−を少しずつ加えなが
ら良く練り合わせてパテ状にした。これを実施例/と同
様な方法で造粒し、96幅収率でg−9メツシユ(s、
o o −s、3g exφ)の範囲のペレットを得た
。Water to this powder mixture: 1! ;9- was added little by little and kneaded well to form a putty. This was granulated in the same manner as in Example/, and g-9 mesh (s,
Pellets in the range of o o −s, 3 g exφ) were obtained.
実施例1と同一のコーテイング液を用い、コーティング
層の重量が被覆された粒子全体のコ9.3 wt%にな
るまで被覆を行った。Using the same coating solution as in Example 1, coating was carried out until the weight of the coating layer became 9.3 wt% of the entire coated particles.
1、−IJレジン酢酸塩を核剤とする粒子の被覆物をM
cdougall緩衝溶液中39℃でコグ時間振盪後保
持されていfcL −IJレジン酢酸塩はg。1. - The coating of particles using IJ resin acetate as a nucleating agent is M
The fcL-IJ resin acetate is kept at 39 °C in cDougall buffer solution after shaking for a cog period.
多であった。また、C1ark Luba 緩衝溶液
中J9Cで2時間振盪するとL −IJレジン酢酸塩は
ioθ幅浴出した。There were many. In addition, when shaken for 2 hours at J9C in C1ark Luba buffer solution, the L-IJ resin acetate was ioθ-extracted.
〔実施例6〕
L−リジンリンゴ酸塩[Lye :リンゴ酸−ユ: /
(mol /mol ) 〕56.0?、ポリビニル
ピロリドン(K−qo):1.32ステアリン酸ナトリ
ウム/ j、! i、マイクロクリスタリンセルロース
/3LiFを乳鉢で混合することによシ実質的に均質な
混合物を得た。此の粉末状混合物に水/ユ?を少しずつ
加えながら良く練り合わせてパテ状にした。これを実施
例1と同様な方法で造粒しg−9メツシユ(=、o o
−コ、J g−φ)の範囲のベレットを得た。[Example 6] L-lysine malate [Lye: malic acid-U: /
(mol/mol) ]56.0? , polyvinylpyrrolidone (K-qo): 1.32 sodium stearate/j,! i. Microcrystalline cellulose/3LiF was mixed in a mortar to obtain a substantially homogeneous mixture. Add water to this powder mixture? was added little by little and kneaded well to form a putty. This was granulated in the same manner as in Example 1 to form a g-9 mesh (=, o o
- J g - φ) were obtained.
さらに、実施例/と同一のコーテイング液でコーティン
グ層の重量が被覆された粒子全体の29、’l vt%
になるまで被覆を行った。Furthermore, the weight of the coating layer was 29,'l vt% of the total coated particles with the same coating liquid as in Example/.
The coating was carried out until it became .
L−リジンのリンゴ酸塩を核剤とする粒子の被覆物をM
edougB11緩衝溶液中39Cで2弘時間振盪後保
持されていたL−リジンのリンゴ酸塩は9り、コチであ
った。また、C1ark Lubs 緩衝溶液中、?
qCで3時間振盪するとL−リジンのリンゴ酸塩はg
g、i%溶出した。The particle coating using L-lysine malate as a nucleating agent is M
The malate of L-lysine retained after shaking for 2 hours at 39C in Edoug B11 buffer solution was 9. Also, in C1ark Lubs buffer solution?
When shaken for 3 hours at qC, malate of L-lysine is g
g, i% eluted.
−27=
〔実施例り〕
L−リジンのグルタミン酸塩s OP、酢酸カルシウム
i’o、o1.ポリビニルピロリドン(K−q o )
s、09−を乳鉢で混合することによりほぼ均質な混
合物を得た。此の粉末状混合物に水107を少しずつ加
えながら良く練シ合わせてパテ状にした。実施例1と同
様な方法で造粒し、95%収率テl−9メツシュ(2,
00−:2,31ツφ)の範囲のベレットを得た。実施
例/と同じ方法でコーティングしコーティング層の重量
が被覆された粒子全体の、2 ?、7 wt%になるま
で被覆を行った。-27= [Example] L-lysine glutamate s OP, calcium acetate i'o, o1. Polyvinylpyrrolidone (K-qo)
A substantially homogeneous mixture was obtained by mixing s, 09- in a mortar. Water 107 was added little by little to this powdery mixture and kneaded well to form a putty. Granulation was carried out in the same manner as in Example 1, yielding 95% yield Tel-9 mesh (2,
A pellet having a diameter of 00-:2,31 mm was obtained. It was coated in the same manner as in Example/, and the weight of the coating layer was 2? , 7 wt%.
L−リジンのグルタミン酸塩を核剤とする粒子の被堕物
をMadougall緩衝溶液中、yqcでニゲ時間振
盪後保持されていたL−リジンのグルタミン酸塩は97
.9%であった。また+ C1arkLub@ 緩衝
溶液中、??’Cでコ時間振盪するとL−リジンのグル
タミン酸塩はqq%溶出した。The glutamate of L-lysine that was retained after shaking the particles with glutamate of L-lysine as a nucleating agent in Madougall buffer solution for a long time with YQC was 97.
.. It was 9%. Also +C1arkLub@ in buffer solution? ? After shaking for hours at 10°C, qq% of L-lysine glutamate was eluted.
L−リジンのアスパラギン酸塩30y−1酢酸カルシウ
ム/ 0.01i1−、ポリビニルピロリドン(K−9
0) 5、Offを乳鉢で混合することによりほぼ均質
な混合物を得た。此の粉末状混合物に水10fを少しず
つ加えながら良く練り合わせてパテ状にした。実施例1
と同様な方法で造粒し、g−9メツシ:x−(2,0o
−x、3 g rranφ)の範囲のペレットを得た。L-lysine aspartate 30y-1 calcium acetate/0.01i1-, polyvinylpyrrolidone (K-9
0) 5.Off was mixed in a mortar to obtain a substantially homogeneous mixture. 10 f of water was added little by little to this powdery mixture and kneaded well to form a putty. Example 1
Granulate in the same manner as g-9 mesh:x-(2,0o
-x, 3 g rranφ) were obtained.
実施例1と同じ方法でコーティングしコーティング層の
重量が被覆された粒子全体のコ9.6wt%になるまで
被覆を行った。Coating was performed in the same manner as in Example 1 until the weight of the coating layer became 9.6 wt % of the entire coated particles.
L−リジンのアスパラギン酸塩を核剤とする粒子の被覆
物をMadougall緩衝溶液中39℃で21I時間
振盪後保持されていたL−リジンのアスパラギン酸塩は
100%であった。また、C1ark Lubl 緩
衝溶液中39℃でコ時間振盪するとL−リジンのアスパ
ラギン酸塩は100%溶出した。After shaking the particles coated with L-lysine aspartate as a nucleating agent at 39° C. in Madougall's buffer solution for 21 hours, the L-lysine aspartate retained was 100%. Further, when the mixture was shaken in a C1ark Lubl buffer solution at 39° C. for several hours, 100% of the aspartate of L-lysine was eluted.
〔実施例9〕
L−リジン−塩酸塩’)3f、酢酸ナトリウム209−
、マイクロクリスタリンセルロース/4’2、ポリビニ
ルピロリド7(K−qo)3.Ofを乳鉢で混合するこ
とによりほぼ均質な混合物を得た。此の粉末状混合物に
水/ 11.09−を少しずつ加えながら良く練9合わ
せてパテ状にした。[Example 9] L-lysine-hydrochloride') 3f, sodium acetate 209-
, microcrystalline cellulose/4'2, polyvinylpyrrolid 7 (K-qo)3. A nearly homogeneous mixture was obtained by mixing Of in a mortar. Water was added little by little to this powdery mixture and kneaded well to form a putty.
これを実施例/と同様な方法で造粒し1g−9メツシユ
(2,00−2,3grrrmφ)の範囲のベレットを
得た。This was granulated in the same manner as in Example/1 to obtain pellets in the range of 1 g-9 mesh (2,00-2,3 grrrmφ).
実施%iと同一のコーテイング液を用い、実施例/と同
様の方法で、コーティング層の重量が被覆された粒子全
体の、7 o、a vt%になるまで被覆を行った。Using the same coating solution as in Example %i, coating was carried out in the same manner as in Example/until the weight of the coating layer reached 7 o,avt% of the total coated particles.
L IJレジン酸塩を核剤とする粒子の被覆物をMc
dougall緩衝溶液中39℃でコグ時間振盪後保持
されていたl、 −IJリジン塩96.9%であった。Mc
96.9% of the l,-IJ lysine salt was retained after shaking for a cog hour at 39 °C in Dougall's buffer solution.
また、C1ark Lubs 緩衝溶液中39℃で3
時間振盪するとI、 IJリジン塩/ 00.0%溶
出した。In addition, 3% at 39°C in C1ark Lubs buffer solution.
After shaking for an hour, I and IJ lysine salts/00.0% were eluted.
L IJリジン塩酸塩3oz、カルボン酸カルシウム
塩61.タルク/ OA; f、ポリビニルピロリドン
(K−qo)t、sf/を乳鉢で混合することによシは
ぼ均質な混合物を得た。此の粉末状混合物に水lユ、O
fな少しずつ加えながら良く練シ合わせてパテ状にした
。これを実施例1と同様な方法で造粒し1g−9メツシ
ユ(ユ、00−ユ、3gMφ)の範囲のベレットを得た
。L IJ lysine hydrochloride 3oz, carboxylic acid calcium salt 61. A nearly homogeneous mixture was obtained by mixing talc/OA; f, polyvinylpyrrolidone (K-qo)t, and sf/ in a mortar. Add 1 liter of water and O to this powdered mixture.
Add the ingredients little by little and knead well to form a putty. This was granulated in the same manner as in Example 1 to obtain pellets in the range of 1g-9 mesh (YU, 00-YU, 3gMφ).
実施例1と同一のコーテイング液を用い、実施例/と同
様の方法で、コーティング層の重量が被覆された粒子全
体の30.Owt係になるまで被覆を行った。Using the same coating solution as in Example 1 and using the same method as in Example 1, the weight of the coating layer was 30.0% of the total coated particles. Covering was carried out until it reached Owt level.
L −IJリジン塩酸塩を核剤とする粒子の被覆物をM
cdougall緩衝溶液中39’Cでコグ時間振盪後
保持されていたL−IJリジン塩酸塩および、C1ar
k Lubs 緩衝溶液中39℃で3時間振盪した際
のL−リジン−塩酸塩の溶出量は表1の通シであった。M
L-IJ lysine hydrochloride which was retained after shaking for a cog period at 39'C in cdougall buffer solution and C1ar
The amount of L-lysine-hydrochloride eluted during shaking at 39° C. for 3 hours in the k Lubs buffer solution was as shown in Table 1.
〔実施例13〕
L−リジン−塩酸塩s o y、コハク酸二ナトリウム
塩Sψ、タルク22.3fP、ポリビニルピロリドン(
’K −90) 2.S Pを乳鉢で混合することによ
りeまは均質な混合物を得た。此の粉末状混合物に水/
2.Ofを少しずつ加えながら良く練り合わせてパテ
状にした。これを実施例1と同様な方法で造粒し、g−
9メツシュCx、oθ−一、31frMLφ)の範囲の
ベレットを得た。[Example 13] L-lysine-hydrochloride so y, succinic acid disodium salt Sψ, talc 22.3 fP, polyvinylpyrrolidone (
'K -90) 2. A homogeneous mixture was obtained by mixing SP in a mortar. Add water to this powder mixture/
2. Add Of little by little and knead well to form a putty. This was granulated in the same manner as in Example 1, and g-
A pellet with a range of 9 mesh Cx, oθ-1, 31 frMLφ) was obtained.
実施例1と同一のコーテイング液を用い、実施例1と同
様の方法で、コーティング層の重量が被覆された粒子全
体の30.3 wt%になるまで被覆を行った。Using the same coating solution as in Example 1, coating was performed in the same manner as in Example 1 until the weight of the coating layer became 30.3 wt% of the entire coated particles.
L IJレジン酸塩を核剤とする粒子の被覆物をMcd
ougall緩衝溶液中39℃でニゲ時間振盪後保持さ
れていたL−リジン塩はり乙、コチであった。また、C
1ark Lubs 緩衝溶液中39℃で2時間振盪
するとL−リジン塩はioo、θチ溶出した。Mcd coating of particles using L IJ resinate as a nucleating agent
The L-lysine salt that was kept at 39°C in Ougall's buffer solution for several hours after shaking was flathead. Also, C
When the mixture was shaken in a 1ark Lubs buffer solution at 39° C. for 2 hours, L-lysine salt was eluted in ioo and θ.
〔比較例1〕
L−リジンの塩酸塩lθoy−マイクロクリスタリンセ
ルロース/ 05+−、アラビアゴムハOy−を乳鉢で
混合することによりほぼ均質な混合物を得た。此の粉末
状混合物に水35g−を少しずつ加えながら良く練り合
わせてパテ状にした。[Comparative Example 1] A substantially homogeneous mixture was obtained by mixing L-lysine hydrochloride lθoy-microcrystalline cellulose/05+- and gum arabic Oy- in a mortar. 35 g of water was added little by little to this powdery mixture and kneaded well to form a putty.
これを実施例1と同様な方法で造粒し、g−9メツシユ
(s、o o−2,3grmφ)の範囲の粒子を得た。This was granulated in the same manner as in Example 1 to obtain particles in the range of g-9 mesh (s, o o -2,3 grmφ).
9−ビニルピリジンどスチレンとの70:30重冒比の
共重合体(エタノール中0.!/diでの還元粘反:η
sp/c−θ、り5)3θ?、アルミニウム粉末3.2
.j 1il−、タルク粉末、72J jil−、ステ
アリン酸5Zの混合物にエチルアルコール!−02を加
えて箪温で3時間攪拌しコーテイング液を調整した。実
施例1と同様の方法でコーティングし、コーティング層
の重量が被偵された粒子全体の30.Q wt循になる
1で被覆を行った。Copolymer with 9-vinylpyridine and styrene in a 70:30 ratio (reduced viscosity reaction at 0.!/di in ethanol: η
sp/c-θ, ri5) 3θ? , aluminum powder 3.2
.. Ethyl alcohol in a mixture of j 1il-, talc powder, 72J jil-, stearic acid 5Z! -02 was added and stirred at room temperature for 3 hours to prepare a coating liquid. Coating was performed in the same manner as in Example 1, and the weight of the coating layer was 30% of the total particle size. Coating was carried out with 1 which becomes Qwt circulation.
[、−IJリジン塩酸塩を核剤とする粒子の被覆物をM
cdougall緩衝溶液中39Cで:ltI時間振盪
後保持されていたL −IJリジン塩酸塩は2五〇%に
すぎなかったC、また、 C1ark Lubg 緩
衝溶済中390で二時間振盪するとL IJリジン塩
酸塩はt00%溶出した。[,-IJ The particle coating using lysine hydrochloride as a nucleating agent is
At 39C in Cdougall buffer solution, only 250% of L-IJ lysine hydrochloride was retained after shaking for 1 hours; The salt was eluted at t00%.
L−リジン−塩酸1boy、ポリビニルピロリド7(K
−qo)sy、メルクtOf、エチルアルコールisl
を少しずつ加えながら良く練p合せてパテ状にした。こ
れを実施例1と同様な方法で造粒し、g−9メツシユ(
,2,OO−ユ、3 If關φ)の範囲の粒子を得た。L-lysine-hydrochloric acid 1 boy, polyvinylpyrrolid 7 (K
-qo)sy, MercktOf, ethyl alcohol isl
The mixture was added little by little and kneaded well to form a putty. This was granulated in the same manner as in Example 1, and g-9 mesh (
, 2, OO-U, 3 If關φ) were obtained.
実施例1で用いたものと同一・の被覆用の懸濁液で被覆
し、コーティング層の重量が被覆された粒子全体の30
.0wt%になる1で被覆した。The coating suspension was coated with the same coating suspension as used in Example 1, and the weight of the coating layer was 30% of the total coated particles.
.. It was coated with 1 to give 0 wt%.
L−リジン塩はMcdougal 1 緩衝溶液中39
℃で2ダ時間振盪後、2g、θ%が保持されていたにす
ぎない。′=18た、C1ark−Lubs 緩衝溶
液中で39′cでユ時間振盪することによりL−リジン
塩は700.0%浴出した。L-lysine salt in McDougal 1 buffer solution 39
After shaking for 2 hours at °C, only 2g, θ% was retained. 700.0% of the L-lysine salt was leached out by shaking in C1ark-Lubs buffer solution for 1 hour at 39'C.
= 35−
〔試験方法〕
内容績300−の三角フラスコに実施例で得られた反芻
動物用栄養剤19−を加え第一胃液に※1
対応・するMcdougall 人口唾液または第四
胃液※2
に対応、するC1ark−Lubs の人口胃液、
2oomtをそれぞれ加え、39±O,SCの恒温槽中
で幾幅tIcrrIで、−分間に?/回の往復振動を与
えつつ、振盪した。= 35- [Test method] Add the ruminant nutrient 19- obtained in the example to an Erlenmeyer flask with a content grade of 300-. , C1ark-Lubs artificial gastric juice,
Add 2 oomt each and incubate for -min at tIcrrI in a constant temperature bath at 39±O, SC. It was shaken while applying reciprocating vibration / times.
Madougall緩@溶液では二り時間後、C1ar
kLubs の緩衝溶液では3時間後の塩基性アミノ
酸塩の溶出率は高速液体クロマトグラフィーを用いて定
量した。In Madougall's mild solution, after 2 hours, C1ar
In the kLubs buffer solution, the elution rate of the basic amino acid salt after 3 hours was determined using high performance liquid chromatography.
※I Mcdaugall緩衝溶液
マグネシウム・6水塩o、1otl、塩化カルシウムo
、o 、t yを水/1に溶解し、炭酸ガスを飽和させ
て調整した( pHt、、g )。*I McDaugall buffer solution magnesium hexahydrate o, 1 otl, calcium chloride o
, o, and ty were dissolved in 1/1 water and saturated with carbon dioxide gas to adjust the pH (pHt,,g).
※2 C1ark−Lubs緩衝溶液0.2 N塩化
カリウム50−および0.2N塩酸/ 0./、−を水
/39.’1mば加えて調整した( pHs、o )。*2 C1ark-Lubs buffer solution 0.2N potassium chloride 50- and 0.2N hydrochloric acid/0. /, - is water /39. '1 m was added and adjusted (pHs, o).
(発明の効果)
特定の物質を核剤とすることにより、塩基性炭酸マグネ
シウムや水酸化マグネシウムなどの塩基性物質を必要と
しない。したがって、本発明の添加剤によれば、従来の
公知の添加剤に比較し、比重の小さいものが得られ、第
−胃における保護性が向上する。(Effect of the invention) By using a specific substance as a nucleating agent, basic substances such as basic magnesium carbonate and magnesium hydroxide are not required. Therefore, the additive of the present invention has a lower specific gravity than conventional known additives, and the protection in the rumen is improved.
すなわち、アミノ酸の塩を被覆剤で被覆してなる飼料添
加剤の比重は、核剤としてのアミノ酸の塩のみならず、
被懐剤の組成によっても異なるが、添加剤の比重を小さ
くし得ることは。In other words, the specific gravity of a feed additive made by coating an amino acid salt with a coating agent is determined not only by the amino acid salt as a nucleating agent but also by
Although it varies depending on the composition of the drug to be treated, it is possible to reduce the specific gravity of the additive.
被覆された粒子の比重を小さく制御できることになる。This means that the specific gravity of the coated particles can be controlled to be small.
その結果、前述のごとく、被覆粒子の有効利用率を高め
ることが出来る。As a result, as described above, the effective utilization rate of the coated particles can be increased.
Claims (6)
ン酸のアルカリ金属塩もしくはアルカリ土類金属塩とを
含有する核を、pH5以下の酸性領域で水に溶解もしく
は膨潤する高分子の少なくとも一種の被覆剤で被覆して
なる反芻動物用飼料添加組成物。(1) At least one type of polymer that dissolves or swells in water in an acidic region of pH 5 or less, with a core containing at least one kind of basic amino acid salt and an alkali metal salt or alkaline earth metal salt of a carboxylic acid. A feed additive composition for ruminants coated with a coating agent.
酸、フマール酸、クエン酸、ラウリン酸、パルミチン酸
、および、ステアリン酸から成る群より選ばれる化合物
であることを特徴とする特許請求範囲第1項記載の動物
用飼料添加組成物。(2) The carboxylic acid is a compound selected from the group consisting of acetic acid, propionic acid, lactic acid, succinic acid, fumaric acid, citric acid, lauric acid, palmitic acid, and stearic acid. The animal feed additive composition according to item 1.
と(メタ)アクリル酸アルキルエステルよりなる共重合
体、または2−メチル−5−ビニルピリジン、2−ビニ
ルピリジン、4−ビニルピリジン、2−ビニル−6−メ
チルピリジン、2−ビニル−5−エチルピリジンの群か
ら選ばれたビニルピリジン類と(メタ)アクリル酸アル
キルエステル、(メタ)アクリル酸、アクリロニトリル
の群から選ばれたアクリル化合物あるいはスチレンとの
共重合体である特許請求範囲第1項記載の動物用飼料添
加組成物。(3) The coating material is a copolymer of dimethylaminoethyl methacrylate and (meth)acrylic acid alkyl ester, or 2-methyl-5-vinylpyridine, 2-vinylpyridine, 4-vinylpyridine, 2-vinyl-6 - A combination of vinylpyridine selected from the group of methylpyridine and 2-vinyl-5-ethylpyridine and an acrylic compound selected from the group of (meth)acrylic acid alkyl ester, (meth)acrylic acid, and acrylonitrile, or styrene. The animal feed additive composition according to claim 1, which is a polymer.
00重量部である特許請求範囲第1項記載の動物用飼料
添加組成物。(4) The ratio of coating agent used is 10 to 2 parts by weight per 100 parts by weight of the core.
00 parts by weight of the animal feed additive composition according to claim 1.
項記載の動物用飼料添加組成物。(5) Claim 1 in which the ruminant is a cow, sheep, or goat
The animal feed additive composition described in Section 1.
スチジン、オルニチンから選ばれたアミノ酸の塩酸塩、
酢酸塩、酪酸塩、フマール酸塩、吉草酸塩、ラウリン酸
塩、パルミチン酸塩から選ばれたカルボン酸塩、アスパ
ラギン酸塩、またはグルタミン酸塩であることを特徴と
する特許請求範囲第1項記載の動物用飼料添加組成物。(6) the basic amino acid salt is an amino acid hydrochloride selected from lysine, arginine, histidine, ornithine;
Claim 1, characterized in that the salt is a carboxylate, aspartate, or glutamate selected from acetate, butyrate, fumarate, valerate, laurate, palmitate. An animal feed additive composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61243729A JPS6398359A (en) | 1986-10-14 | 1986-10-14 | Feed additive composition for ruminant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61243729A JPS6398359A (en) | 1986-10-14 | 1986-10-14 | Feed additive composition for ruminant |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6398359A true JPS6398359A (en) | 1988-04-28 |
Family
ID=17108122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61243729A Pending JPS6398359A (en) | 1986-10-14 | 1986-10-14 | Feed additive composition for ruminant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6398359A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996017822A1 (en) * | 1994-12-09 | 1996-06-13 | Ajinomoto Co., Inc. | Novel complex salts of phosphoric and amino acids and ruminant feed additive composition containing the same |
EP0781512A3 (en) * | 1995-12-27 | 1999-09-08 | Ajinomoto Co., Inc. | Ruminant feed additive compositon containing novel phosphoric acid-amino acid- polyvalent metal composite salt |
JPWO2006001345A1 (en) * | 2004-06-23 | 2008-04-17 | 協和醗酵工業株式会社 | L-lysine citrate crystals |
JP2010539976A (en) * | 2007-10-05 | 2010-12-24 | エイチ ジェイ ベーカー アンド ブラザー インコーポレイテッド | Granular feed supplement |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6137054A (en) * | 1984-07-31 | 1986-02-21 | Mitsui Toatsu Chem Inc | Particle for feed additive |
-
1986
- 1986-10-14 JP JP61243729A patent/JPS6398359A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6137054A (en) * | 1984-07-31 | 1986-02-21 | Mitsui Toatsu Chem Inc | Particle for feed additive |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996017822A1 (en) * | 1994-12-09 | 1996-06-13 | Ajinomoto Co., Inc. | Novel complex salts of phosphoric and amino acids and ruminant feed additive composition containing the same |
KR100407088B1 (en) * | 1994-12-09 | 2004-03-30 | 아지노모토 가부시키가이샤 | Secondary Phosphoric Acid-Amino Acid Composite Salts, and Additives for Use in Feed for Ruminant Mammals Containing Such Salts |
EP0781512A3 (en) * | 1995-12-27 | 1999-09-08 | Ajinomoto Co., Inc. | Ruminant feed additive compositon containing novel phosphoric acid-amino acid- polyvalent metal composite salt |
JPWO2006001345A1 (en) * | 2004-06-23 | 2008-04-17 | 協和醗酵工業株式会社 | L-lysine citrate crystals |
JP4796493B2 (en) * | 2004-06-23 | 2011-10-19 | 協和発酵バイオ株式会社 | L-lysine citrate crystals |
JP2010539976A (en) * | 2007-10-05 | 2010-12-24 | エイチ ジェイ ベーカー アンド ブラザー インコーポレイテッド | Granular feed supplement |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4996067A (en) | Feed additive for ruminants | |
JPH0479844A (en) | Feed additive for ruminant | |
JP2546852B2 (en) | Feed additive coated with a ruminant feed additive coating composition | |
US5080917A (en) | Oral compositions for ruminants | |
US4937083A (en) | Feed additive for ruminants | |
JPH06141785A (en) | Feed additive composition for ruminant | |
JPH0720423B2 (en) | Feed additives for ruminants | |
US4976976A (en) | Feed additive for ruminants | |
WO2004080210A1 (en) | Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea | |
JPS6398359A (en) | Feed additive composition for ruminant | |
JPS59198946A (en) | Feed additive | |
JPS6398360A (en) | Reed additive composition for ruminant | |
JPS61195653A (en) | Particle for ruminant | |
JPH05192096A (en) | Feed additive composition for ruminant | |
US5616339A (en) | Chitosan-based nutrient or medicinal compositions for administration to ruminants | |
JPS60168351A (en) | Feed additive composition | |
JPH10215789A (en) | Feed additive for ruminant | |
JPS6398357A (en) | Feed additive composition for ruminant | |
JPH0829052B2 (en) | Feed additives for ruminants | |
JPS6255047A (en) | Composition for feeding ruminant | |
JPS6188844A (en) | Feed additive composition for ruminant | |
JP2645497B2 (en) | Ruminant feed additives | |
JPH0789876B2 (en) | Feed additives for ruminants | |
JPS63245641A (en) | Feed additive composition for ruminant | |
JPS6188843A (en) | Feed additive composition for ruminant |